Amber Capital Management LP Has Upped Its Gran Tierra Energy (GTE) Stake, Voya Investment Management Has Increased Its Aerie Pharmaceuticals (AERI) Holding

June 19, 2017 - By Vivian Park

Voya Investment Management Llc increased Aerie Pharmaceuticals Inc (AERI) stake by 2523.76% reported in 2016Q4 SEC filing. Voya Investment Management Llc acquired 268,326 shares as Aerie Pharmaceuticals Inc (AERI)’s stock declined 8.47%. The Voya Investment Management Llc holds 278,958 shares with $10.56 million value, up from 10,632 last quarter. Aerie Pharmaceuticals Inc now has $1.76B valuation. The stock rose 0.20% or $0.1 reaching $50.15 per share. About 320,519 shares traded. Aerie Pharmaceuticals Inc (NASDAQ:AERI) has risen 180.20% since June 19, 2016 and is uptrending. It has outperformed by 163.50% the S&P500.

Amber Capital Management Lp increased Gran Tierra Energy Inc (GTE) stake by 7.01% reported in 2016Q4 SEC filing. Amber Capital Management Lp acquired 779,269 shares as Gran Tierra Energy Inc (GTE)’s stock declined 6.20%. The Amber Capital Management Lp holds 11.89 million shares with $35.92M value, up from 11.12 million last quarter. Gran Tierra Energy Inc now has $897.33M valuation. The stock declined 2.86% or $0.07 reaching $2.2 on the news. About 490,751 shares traded. Gran Tierra Energy Inc (NYSEMKT:GTE) has declined 7.89% since June 19, 2016 and is downtrending. It has underperformed by 24.59% the S&P500.

Since February 14, 2017, it had 1 insider purchase, and 2 sales for $3.02 million activity. Another trade for 1,000 shares valued at $39,900 was bought by Cagle Gerald D.. Shares for $1.94M were sold by DUYK GEOFFREY M on Tuesday, February 14. Shares for $1.12M were sold by Foresite Capital Management II – LLC.

Voya Investment Management Llc decreased Erie Indty Co (NASDAQ:ERIE) stake by 11,351 shares to 10,392 valued at $1.17M in 2016Q4. It also reduced Rpm Intl Inc (NYSE:RPM) stake by 27,448 shares and now owns 85,486 shares. Dollar Tree Inc (NASDAQ:DLTR) was reduced too.

Among 11 analysts covering Aerie Pharmaceuticals (NASDAQ:AERI), 11 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Aerie Pharmaceuticals had 22 analyst reports since August 7, 2015 according to SRatingsIntel. On Thursday, September 15 the stock rating was maintained by RBC Capital Markets with “Outperform”. The rating was initiated by Aegis Capital with “Buy” on Tuesday, November 1. The stock of Aerie Pharmaceuticals Inc (NASDAQ:AERI) has “Market Outperform” rating given on Wednesday, September 9 by JMP Securities. The stock of Aerie Pharmaceuticals Inc (NASDAQ:AERI) earned “Buy” rating by Stifel Nicolaus on Thursday, October 6. The stock of Aerie Pharmaceuticals Inc (NASDAQ:AERI) has “Buy” rating given on Tuesday, September 20 by H.C. Wainwright. The firm earned “Buy” rating on Friday, August 7 by Cantor Fitzgerald. As per Thursday, September 17, the company rating was maintained by Stifel Nicolaus. RBC Capital Markets maintained the shares of AERI in report on Friday, October 28 with “Outperform” rating. The firm has “Buy” rating given on Tuesday, December 20 by Canaccord Genuity. The stock has “Buy” rating by Cantor Fitzgerald on Thursday, September 15.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: